Stefanie Menzies

Has grant

University of Lancaster

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Establishing an animal-free monoclonal antibody discovery and maturation pipeline to accelerate new therapies and diagnostic tools for NTDs

Open Date: 2022-10-01

Close Date: 2024-03-01

Grant: Close

Training in phage-display antibody libraries

Open Date: 2022-08-01

Close Date: 2022-08-01

Grant: Close

Establishment and validation of an in-house monoclonal antibody (mAb) discovery pipeline

Open Date: 2022-05-01

Close Date:

Grant: Close

Development of a context- appropriate rapid diagnostic test for snakebite in sub- Saharan Africa

Open Date: 2020-10-01

Close Date: 2021-07-01

Grant: Close

Intra-mitochondrial Glycosylation – a New Paradigm of Eukaryotic Glycobiology

Open Date: 2018-07-01

Close Date: 2018-08-01

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Lecturer

St George’s, University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefanie Menzies

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages

Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins

Next-Generation Sequencing for Venomics: Application of Multi-Enzymatic Limited Digestion for Inventorying the Snake Venom Arsenal

ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming

SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing

Virus-like particles displaying conserved toxin epitopes stimulate broadly reactive, polyspecific, murine antibody responses capable of snake venom recognition

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

Collaborators (10)

Quinton Loïc

Steven Hall

Rachel Clare

Emanuele Giorgi

Nicholas Casewell

Sophie Owen

Imre Berger

Gabriel Mazzucchelli

Christiane Helene Berger-Schaffitzel

Henry Staines

Make your next move.